Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,229 | 245 | 99.7% |
| Education | $10.76 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $772.91 | 69 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $708.83 | 58 | $0 (2022) |
| Grifols USA, LLC | $311.19 | 28 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $226.80 | 13 | $0 (2018) |
| Respiratory Technologies, Inc. | $170.60 | 9 | $0 (2017) |
| Mylan Specialty L.P. | $116.69 | 7 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $106.43 | 7 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $99.30 | 8 | $0 (2018) |
| Astellas Pharma US Inc | $84.58 | 5 | $0 (2018) |
| Philips Electronics North America Corporation | $80.08 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $107.10 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($107.10) |
| 2021 | $13.36 | 1 | GlaxoSmithKline, LLC. ($13.36) |
| 2018 | $1,370 | 98 | GlaxoSmithKline, LLC. ($461.37) |
| 2017 | $1,749 | 149 | Boehringer Ingelheim Pharmaceuticals, Inc. ($355.16) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $107.10 | General |
| 12/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/26/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.01 | General |
| 10/17/2018 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Cardio-pulmonary | ||||||
| 10/15/2018 | Mylan Specialty L.P. | Perforomist (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Respiratory and Allergy | ||||||
| 10/13/2018 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 10/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Respiratory | ||||||
| 10/03/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2018 | Advanced Respiratory, Inc | The Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Airway Clearance Device | ||||||
| 09/20/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2018 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/12/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.48 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 60 | 84 | $15,908 | $5,344 |
| 2022 | 5 | 137 | 204 | $45,715 | $13,709 |
| 2021 | 6 | 142 | 218 | $46,955 | $15,081 |
| 2020 | 2 | 38 | 58 | $13,683 | $4,034 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $4,318 | $1,631 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 21 | $3,612 | $1,421 | 39.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 22 | $3,850 | $1,273 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 24 | $4,128 | $1,019 | 24.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 60 | $15,180 | $4,633 | 30.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 32 | 51 | $8,925 | $2,712 | 30.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $7,380 | $2,193 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 30 | $5,160 | $1,696 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 37 | $6,364 | $1,693 | 26.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,706 | $781.10 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 87 | $15,225 | $4,813 | 31.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 40 | $10,120 | $3,180 | 31.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 26 | $4,472 | $1,735 | 38.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $5,412 | $1,695 | 31.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 18 | $4,572 | $1,446 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 23 | $3,956 | $1,203 | 30.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $3,198 | $1,010 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 43 | $11,058 | $3,178 | 28.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 15 | $2,625 | $855.60 | 32.6% |
About Dr. Bogdan Moldoveanu, MD
Dr. Bogdan Moldoveanu, MD is a Pulmonary Disease healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518062439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bogdan Moldoveanu, MD has received a total of $3,239 in payments from pharmaceutical and medical device companies, with $107.10 received in 2022. These payments were reported across 249 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,229).
As a Medicare-enrolled provider, Moldoveanu has provided services to 377 Medicare beneficiaries, totaling 564 services with total Medicare billing of $38,167. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Louisville, KY
- Active Since 09/14/2006
- Last Updated 11/30/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1518062439
Products in Payments
- Prolastin-C (Biological) $311.19
- STIOLTO (Drug) $288.59
- BREO (Drug) $231.54
- STIOLTO RESPIMAT (Drug) $204.30
- NUCALA (Biological) $185.41
- TRELEGY ELLIPTA (Drug) $176.82
- ANORO (Drug) $165.77
- SYMBICORT (Drug) $151.32
- Perforomist (Drug) $116.69
- Xyrem (Drug) $106.43
- OFEV (Drug) $90.04
- Adempas (Drug) $66.52
- Wellcentive Undiv (Device) $56.21
- QVAR (Drug) $54.94
- Xolair (Biological) $52.92
- CRESEMBA (Drug) $52.66
- CINQAIR (Drug) $44.36
- SMARTVEST (Device) $43.59
- NIOX VERO DEVICE (Device) $43.25
- Kcentra (Biological) $40.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Louisville
Dr. John Mcconnell, M.d, M.D
Pulmonary Disease — Payments: $1.0M
Harold Haller, Md, MD
Pulmonary Disease — Payments: $397,803
Kenneth Anderson, Md, MD
Pulmonary Disease — Payments: $16,989
Dr. Edwin Carmouche, Md, MD
Pulmonary Disease — Payments: $15,169
Dr. Zaka Khan, Md, MD
Pulmonary Disease — Payments: $15,042
Dr. Allan Ramirez, M.d, M.D
Pulmonary Disease — Payments: $12,934